Hennion & Walsh Asset Management’s C4 Therapeutics CCCC Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-223,168	Closed	-$587K	–	961
2026 Q1	$587K	Sell	223,168 -13,969	-6%	-$32.9K	0.02%	671
2025 Q4	$453K	Buy	237,137 +32,104	+16%	+$76.1K	0.02%	741
2025 Q3	$455K	Sell	205,033 -3,733	-2%	-$8.96K	0.02%	730
2025 Q2	$299K	Sell	208,766 -9,645	-4%	-$14K	0.01%	817
2025 Q1	$349K	Sell	218,411 -8,736	-4%	-$26.1K	0.02%	729
2024 Q4	$818K	Buy	227,147 +34,783	+18%	+$173K	0.04%	513
2024 Q3	$1.1M	Buy	192,364 +49,532	+35%	+$298K	0.05%	430
2024 Q2	$660K	Buy	+142,832	New	+$852K	0.03%	517

Other funds holding CCCC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return